Armistice Capital, LLC 13D and 13G filings for ALTAMIRA THERAPEUTICS LTD SHS:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:44 pm Sale | 2025-09-30 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | Armistice Capital, LLC | 189,562 4.990% | -39,022 (-17.07%) | Filing |
| 2025-08-14 9:19 pm Purchase | 2025-06-30 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | Armistice Capital, LLC | 228,584 9.990% | 228,584 (New Position) | Filing |
| 2025-05-15 3:25 pm Sale | 2025-03-31 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | Armistice Capital, LLC | 473,870 9.990% | -4,677 (-0.98%) | Filing |
| 2025-02-14 5:41 pm Purchase | 2024-12-31 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | Armistice Capital, LLC | 478,547 9.990% | 70,437 (+17.26%) | Filing |
| 2024-11-14 3:27 pm Purchase | 2024-09-30 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | Armistice Capital, LLC | 408,110 9.990% | 408,110 (New Position) | Filing |